Deferred Income Tax Assets, Net of SUPERNUS PHARMACEUTICALS, INC. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
SUPERNUS PHARMACEUTICALS, INC. quarterly Deferred Income Tax Assets, Net in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • SUPERNUS PHARMACEUTICALS, INC. Deferred Income Tax Assets, Net for the quarter ending 30 Sep 2025 was $8,793,000.
Source SEC data
View on sec.gov
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Change (%)

SUPERNUS PHARMACEUTICALS, INC. Quarterly Deferred Income Tax Assets, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,793,000 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $6,181,000 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q4 2024 $0 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q4 2020 $0 -$32,063,000 -100% 31 Dec 2020 10-K 08 Mar 2021 2020 FY
Q3 2020 $0 -$27,953,000 -100% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $0 -$25,975,000 -100% 30 Jun 2020 10-Q 17 Aug 2020 2020 Q2
Q1 2020 $34,067,000 +$6,100,000 +22% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $32,063,000 +$2,380,000 +8% 31 Dec 2019 10-K 08 Mar 2021 2020 FY
Q3 2019 $27,953,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $25,975,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $27,967,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $29,683,000 31 Dec 2018 10-K 28 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.